Skip to Content


Publication highlights

Newman SA, Pan Y, Short JL, Nicolazzo JA. Increasing intracellular levels of iron with ferric ammonium citrate leads to reduced P-glycoprotein expression in human immortalised brain microvascular endothelial cells. Pharm Res 38:97-111 (2021) Link

Low YL, Jin L, Morris E, Pan Y, Nicolazzo JA. Pioglitazone increases blood-brain barrier expression of fatty acid-binding protein 5 and docosahexaenoic acid trafficking into the brain. Mol Pharm 17:873-884 (2020) Link

Pan Y, Nicolazzo JA. Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics. Adv Drug Del Rev 135:62-74 (2018) Link

Pan Y, Morris ER, Scanlon MJ, Marriott PJ, Porter CJH, Nicolazzo JA. Dietary docosahexaenoic acid supplementation enhances expression of fatty acid-binding protein 5 at the blood-brain barrier and brain docosahexaenoic acid levels. J Neurochem 146:186-197 (2018) Link

Pan Y, Short JL, Newman SA, Choy KW, Tiwari D, Yap C, Senyschyn D, Banks WA, Nicolazzo JA. Cognitive benefits of lithium chloride in APP/PS1 mice are associated with enhanced brain clearance of β-amyloid. Brain Behav Immun 70:36-47 (2018) Link

Pan Y, Short JL, Choy KHC, Zheng AX, Marriott PJ, Owada Y, Scanlon MJ, Porter CJH, Nicolazzo JA. Fatty acid-binding protein 5 at the blood-brain barrier regulates endogenous brain docosahexaenoic acid levels and cognitive function. J Neurosci 36:11755–11767 (2016) Link

Full publication lists